The role of insulin-like growth factor in prediction and prevention of preterm delivery;Odreivanje uloge faktora rasta sličnog insulinu u predvianju i prevenciji prevremenog poroaja

Vojnosanitetski Pregled

Volumn 67, Issue 11, 2010, Pages 883-886

  Bogavac, Mirjana ^a   Simin, Nataša ^b   Ranisavljević, Milan ^a   Budišić, Ljiljana ^c  

^a CLINICAL CENTER OF VOJVODINA   (Serbia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c Institute of Physiology   (Serbia)

Author keywords

Insulin like growth factor i; Obstetric labor; Placenta; Premature; Rupture; Vaginal smears

Indexed keywords

MONOCLONAL ANTIBODY; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ANTIBODY DETECTION; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; MEDICAL PRACTICE; NEWBORN; PREGNANCY; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; RISK ASSESSMENT; UTERINE CERVIX MUCUS; VAGINA SECRETION;

EID: 78649310894     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1011883B     Document Type: Article

References (18)

1. Kekki M, Kurki T, Paavonen J, Rutanen E-M. Insulin-like growth factor binding protein-1 in cervix as a marker of infectious complications in pregnant women with bacterial vaginosis. Lancet 1999; 353: 1494.
2. Martina NA, Kim E, Chitkara U, Wathen NC, Chard T, Giudice LC. Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. J Clin Endocrinol Metab 1997; 82(6): 1894-8.
3. Jain K, Morris PG. A clinical study to evaluate the usefulness of the MAST test in diagnosing pre-labour rupture of membranes. J Obstet Gynaecol 1998; 18(1): 33-6.
4. Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995; 80(5): 1548-55.
5. Verhaeghe J, Van Herck E, Billen J, Moerman P, Van Assche FA, Giudice LC. Regulation of insulin-like growth factor-I and insulin- like growth factor binding protein-1 concentrations in preterm fetuses. Am J Obstet Gynecol 2003;188(2): 485-91.
6. Lembet A, Eroglu D, Ergin T, Kuscu E, Zeyneloglu H, Batioglu. S, et al. New rapid bed-side test to predict preterm delivery: phosphorylated insulin-like growth factor binding protein-1 in cervical secretion as a predictor of preterm delivery. Acta Obstet Gynecol Scand 2002; 81(8): 706-12.
7. Kekki M, Kurki T, Karkkainen T, Hiilesmaa V, Paavonen J, Rutanen EM. Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery. Acta Obstet Gynecol Scand 2001; 80: 546-51.
8. Darj E, Lyrenäs S. Insulin-like growth factor binding protein-1, a quick way to detect amniotic fluid. Acta Obstet Gynecol Scand 1998; 77: 295-7.
9. Westwood M, Gibson JM, Davies AJ, Young RJ, White A. The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab 1994; 79(6): 1735-41.
10. Rutanen EM, Pekonen F, Kärkkäinen T. Measurement of insulinlike growth factor binding protein-1 in cervical/vaginal secretions: comparison with the ROM-check Membrane Immunoassay in the diagnosis of ruptured fetal membranes. Clin Chim Acta 1993; 214(1): 73-81.
11. Bittar RE, da Fonseca EB, de Carvalho MH, Martinelli S, Zugaib M. Predicting preterm delivery in asymptomatic patients with prior preterm delivery by measurement of cervical length and phosphorylated insulin-like growth factor-binding protein-1. Ultrasound Obstet Gynecol 2007; 29(5): 562-7.
12. Paternoster DM, Muresan D, Vitulo A, Serena A, Battaglirin G, Dell'Avanzo M. Cervical phIGFBP-1 in the evalua- tion of the risk of preterm delivery. Acta Obstet Gynecol Scand 2007; 86: 151-5.
13. Elizur SE, Yinon Y, Epstein GS, Seidman DS, Schiff E, Sivan E. Insulin-like growth factor binding protein-1 detection in preterm labor: evaluation of a bedside test. Am J Perinatol 2005; 22: 305-9.
14. Eroglu D, Yanik F, Oktem M, Zeyneloglu HB, Kuscu E. Prediction of preterm delivery among women with threatened preterm labor. Gynecol Obstet Invest 2007; 64(2): 109-16.
15. Hills FA, Gunn LK, Hardiman P, Thamaratnam S, Chard T. IGFBP-1 in the placenta, membranes and fetal circulation: levels at term and preterm delivery. Early Hum Dev 1996; 44: 71-6.
16. Erdemoglu E, Mungan T. Significance of detecting insulin-like growth factor binding protein-1 in cervicovaginal secretions: Comparison with nitrazine test and amniotic fluid volume assessment. Acta Obstet Gynecol Scand 2004; 83: 622-6.
17. Cvetkovic M, Ljubic A. Protocols of high risk pregnancys. Beograd: Medicina moderna; 2002.
18. Gibbs RS, Karlan BY, Haney AF, Nygaard IE. Danforth's Obstetrics and Gynecology. Philadelphia, PA: Lippincott Williams and Wilkins; 2008.